INCY vs SCSC · P/E 14, rev $5.14B vs P/E 15, rev $3.23B
Incyte Corporation (INCY) versus ScanSource Inc (SCSC) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
ScanSource Inc (SCSC) is a electronics & computer distribution company listed on NASDAQ.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported SCSC revenue for 2026-06-30 was $3.23B. Net income was $78.9M. Revenue was up 6.1% from 2025-06-30 to 2026-06-30. SCSC currently screens at market cap $988.6M and trailing P/E 14.8.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. SCSC currently screens at market cap $988.6M and trailing P/E 14.8.
Not investment advice. Open the INCY and SCSC stock pages for the full models.
Not investment advice.